Antifungal Activity of Nonantifungal Drugs

Afeltra, J.; Verweij, P. E.

doi:10.1007/s10096-003-0947-x

Cited by 63Antifungal resistance and susceptibilityFungal Infections and StudiesFungal Plant Pathogen Control

Antifungal Activity of Nonantifungal Drugs

Afeltra, J., Verweij, P. E.·2003·European Journal of Clinical Microbiology & Infectious Diseases

DOI 10.1007/s10096-003-0947-x

Open this paper in CoChat — free account

Abstract

The antifungal activity of synthetic, nonchemotherapeutic compounds, antineoplastic agents and antibacterial drugs, such as sulphonamides, has been known since the early 20th century (1932). In this context, the term "nonantifungal" is taken to include a variety of compounds that are employed in the management of pathological conditions of nonfungal infectious etiology but have been shown to exhibit broad-spectrum antifungal activity. In this review, the antifungal properties of compounds such as chlorpromazine, proton pump inhibitors, antiarrhythmic agents, cholesterol-lowering agents, antineoplastic and immunosuppressive agents, antiparasitic drugs and antibiotics are described. Since fungi are eukaryotic cells, they share many pathways with human cells, thus increasing the probability of antifungal activity of "nonfungal drugs". The potential of these drugs for treatment of fungal infections has been investigated sporadically using the drugs alone or in combination with "classic" antifungal agents. A review of the literature, supplemented with a number of more recent investigations, suggests that some of these compounds enhance the activity of conventional antifungal agents, eliminate natural resistance to specific antifungal drugs (reversal of resistance) or exhibit strong activity against certain fungal strains in vitro and in animal models. The role of these agents in the epidemiology and in the clinical manifestations of fungal infections and the potential of certain drugs for treatment of invasive fungal infections require further investigation.

Integrity signals

Registry

Crossref · 10.1007/s10096-003-0947-x

Cites

102 of 102 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Such combinations would be advantageous as the basis of a less toxic antifungal therapy.
“Such combinations would be advantageous as the basis of a less toxic antifungal therapy [3] .”
From Statins as antifungal agents (2011) · cites this paper as [3]

Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters
Sanglard, D., Kuchler, K., Ischer, F., Pagani, J. L., Monod, M., & Bille, J. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.11.2378 · Cited by 815 · see citing works
Calcineurin is required for virulence of Cryptococcus neoformans
Odom, A., Muir, S., Lim, E., Toffaletti, D. L., Perfect, J., & Heitman, J. (1997) · The EMBO Journal · doi:10.1093/emboj/16.10.2576 · Cited by 516 · see citing works
Pentamidine: A Review
Sands, M., Kron, M. A., & Brown, R. B. (1985) · Clinical Infectious Diseases · doi:10.1093/clinids/7.5.625 · Cited by 350 · see citing works
Cryptococcus neoformansInfection in Organ Transplant Recipients: Variables Influencing Clinical Characteristics and Outcome
Husain, S., Wagener, M. M., & Singh, N. (2001) · Emerging infectious diseases · doi:10.3201/eid0703.010302 · Cited by 328 · see citing works
Molecular mechanisms of drug resistance in fungi
BOSSCHE, H. V., Marichal, P., & Odds, F. C. (1994) · Trends in Microbiology · doi:10.1016/0966-842x(94)90618-1 · Cited by 255 · see citing works
Potent Synergism of the Combination of Fluconazole and Cyclosporine in Candida albicans
Marchetti, O., Moreillon, P., Glauser, M. P., Bille, J., & Sanglard, D. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.9.2373-2381.2000 · Cited by 252 · see citing works
Human Mycoses: Drugs and Targets for Emerging Pathogens
Georgopapadakou, N. H., & Walsh, T. J. (1994) · Science · doi:10.1126/science.8153622 · Cited by 234 · see citing works
Antifungals: mechanism of action and resistance, established and novel drugs
Georgopapadakou, N. H. (1998) · Current Opinion in Microbiology · doi:10.1016/s1369-5274(98)80087-8 · Cited by 224 · see citing works
Structure-In Vitro Activity Relationships of Pentamidine Analogues and Dication-Substituted Bis-Benzimidazoles as New Antifungal Agents
Poeta, M. D., Schell, W. A., Dykstra, C. C., et al. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.10.2495 · Cited by 223 · see citing works
Emerging and less common fungal pathogens
Fleming, R. V., Walsh, T. J., & Anaissie, E. J. (2002) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(02)00041-7 · Cited by 215 · see citing works
Deep Infections Caused by Scedosporium prolificans: A Report on 16 Cases in Spain and a Review of the Literature
Berenguer, J., Rodrı́guez-Tudela, J. L., Richard, C., Alvarez, M., Sanz, M. Á., Gaztelurrutia, L., Ayats, J., & Martı́nez-Suárez, J. V. (1997) · Medicine · doi:10.1097/00005792-199707000-00004 · Cited by 213 · see citing works
Identification and Expression of Multidrug Transporters Responsible for Fluconazole Resistance in Candida dubliniensis
Moran, G. P., Sanglard, D., Donnelly, S. M., Shanley, D. B., Sullivan, D. J., & Coleman, D. C. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.7.1819 · Cited by 197 · see citing works
Different effects of itraconazole on the pharmacokinetics of fluvastatin and lovastatin
Kivistö, K. T., Kantola, T., & Neuvonen, P. J. (1998) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1998.00034.x · Cited by 171 · see citing works
Epidemiology of opportunistic invasive mycoses.
Kullberg, B. J., & Lashof, A. M. L. O. (2002) · PubMed · Cited by 158 · see citing works
Calcineurin is required for hyphal elongation during mating and haploid fruiting in Cryptococcus neoformans
Cruz, M. C., Fox, D. S., & Heitman, J. (2001) · The EMBO Journal · doi:10.1093/emboj/20.5.1020 · Cited by 150 · see citing works
Chloroquine induces human macrophage killing of Histoplasma capsulatum by limiting the availability of intracellular iron and is therapeutic in a murine model of histoplasmosis.
Newman, S. L., Gootee, L., Brunner, G. D., & Deepe, G. S. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117119 · Cited by 141 · see citing works
Mechanisms and clinical impact of antifungal drug resistance
BOSSCHE, H. V., Warnock, D. W., Dupont, B., Kerridge, D., Gupta, S. S., Improvisi, L., Marichal, P., Odds, F. C., Provost, F., & Ronin, O. (1994) · Medical Mycology · doi:10.1080/02681219480000821 · Cited by 131 · see citing works
Immunosuppressive and Nonimmunosuppressive Cyclosporine Analogs Are Toxic to the Opportunistic Fungal PathogenCryptococcus neoformansvia Cyclophilin-Dependent Inhibition of Calcineurin
Cruz, M. C., Poeta, M. D., Wang, P., Wenger, R. M., Zenke, G., Quesniaux, V. F. J., Movva, N. R., Perfect, J. R., Cardenas, M. E., & Heitman, J. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.1.143-149.2000 · Cited by 129 · see citing works
Chloroquine induces human mononuclear phagocytes to inhibit and kill Cryptococcus neoformans by a mechanism independent of iron deprivation.
Levitz, S. M., Harrison, T. S., Tabuni, A., & Liu, X. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119688 · Cited by 121 · see citing works
Antifungal activity of ibuprofen alone and in combination with fluconazole against Candida species
Pina‐Vaz, C., Sansonetty, F., Rodrigues, A. G., Martinez‐de‐Oliveira, J., Fonseca, A. F., & Mårdh, P. (2000) · Journal of Medical Microbiology · doi:10.1099/0022-1317-49-9-831 · Cited by 120 · see citing works
Disseminated Infection and Colonization by Scedosporium prolificans: A Review of 18 Cases, 1990-1999
Idígoras, P., Pérez‐Trallero, E., Piñeiro, L. D., et al. (2001) · Clinical Infectious Diseases · doi:10.1086/320521 · Cited by 117 · see citing works
Fluconazole plus Cyclosporine: a Fungicidal Combination Effective against Experimental Endocarditis Due to Candida albicans
Marchetti, O., Entenza, J. M., Sanglard, D., Bille, J., Glauser, M. P., & Moreillon, P. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.11.2932-2938.2000 · Cited by 113 · see citing works
Fungicidal activity of cecropin A
DeLucca, A. J., Bland, J. M., Jacks, T. J., Grimm, C. C., Cleveland, T. E., & Walsh, T. J. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.2.481 · Cited by 109 · see citing works
In vitro activity of fluvastatin, a cholesterol-lowering agent, and synergy with flucanazole and itraconazole against Candida species and Cryptococcus neoformans.
Chin, N. X., Weitzman, I., & Della-Latta, P. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.4.850 · Cited by 101 · see citing works
Antimicrobial Activities of Mefloquine and a Series of Related Compounds
Kunin, C. M., & Ellis, W. Y. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.4.848-852.2000 · Cited by 100 · see citing works
A Randomized Trial of Daily and Thrice‐Weekly Trimethoprim‐Sulfamethoxazole for the Prevention ofPneumocystis cariniiPneumonia in Human Immunodeficiency Virus‐Infected Persons
El-Sadr, W. M., Luskin‐Hawk, R., Yurik, T. M., et al. (1999) · Clinical Infectious Diseases · doi:10.1086/520433 · Cited by 94 · see citing works
Therapy of Murine Aspergillosis with Amphotericin B in Combination with Rifampin or 5-Fluorocytosine
Arroyo, J. C., Medoff, G., & Kobayashi, G. S. (1977) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.11.1.21 · Cited by 92 · see citing works
Activity of Amphotericin B, 5-Fluorocytosine, and Rifampin Against Six Clinical Isolates of Aspergillus
Kitahara, M., Seth, V. K., Medoff, G., et al. (1976) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.9.6.915 · Cited by 91 · see citing works
Fungal Plasma Membrane Proton Pumps as Promising New Antifungal Targets
Monk, B. C., & Perlin, D. S. (1994) · Critical Reviews in Microbiology · doi:10.3109/10408419409114555 · Cited by 88 · see citing works
In Vitro Antifungal Activities of a Series of Dication-Substituted Carbazoles, Furans, and Benzimidazoles
Poeta, M. D., Schell, W. A., Dykstra, C. C., et al. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.10.2503 · Cited by 87 · see citing works
Potentiation of the Antifungal Effects of Antibiotics by Amphotericin B
Kwan, C. N., Medoff, G., Kobayashi, G. S., et al. (1972) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.2.2.61 · Cited by 82 · see citing works
DNA topoisomerases from pathogenic fungi: targets for the discovery of antifungal drugs
Shen, L. L., Baranowski, J. L., Fostel, J. M., Montgomery, D., & Lartey, P. A. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.12.2778 · Cited by 82 · see citing works
Antifungal Activity of Local Anesthetics AgainstCandida Species
Pina‐Vaz, C., Rodrigues, A. G., Sansonetty, F., Martinez‐de‐Oliveira, J., Fonseca, A. F., & Mårdh, P. (2000) · Infectious Diseases in Obstetrics and Gynecology · doi:10.1155/s1064744900000168 · Cited by 79 · see citing works
The yeast plasma membrane proton pumping ATPase is a viable antifungal target. I. Effects of the cysteine-modifying reagent omeprazole
Monk, B. C., Mason, A. B., Abramochkin, G., Haber, J. E., Seto‐Young, D., & Perlin, D. S. (1995) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(95)00133-n · Cited by 78 · see citing works
In Vitro Susceptibilities of Zygomycetes to Combinations of Antimicrobial Agents
Dannaoui, É., Afeltra, J., Meis, J. F. G. M., et al. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.8.2708-2711.2002 · Cited by 78 · see citing works
Self-citation
Synergic effects of tactolimus and azole antifungal agents against azole-resistant Candida albican strains
Maesaki, S., Marichal, P., Hossain, M., Sanglard, D., BOSSCHE, H. V., & KOHNO, S. (1998) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/42.6.747 · Cited by 78 · see citing works
Randomized trial with itraconazole, ketoconazole and sulfadiazine in paracoccidioidomycosis
Shikanai‐Yasuda, M. A., Benard, G., Higaki, Y., Negro, G. M. B. D., Hoo, S., Vaccari, E. H., Gryschek, R. C. B., Segurado, A. A. C., Barone, A. A., & Andrade, D. R. (2002) · Medical Mycology · doi:10.1080/mmy.40.4.411.417 · Cited by 77 · see citing works
Amphotericin B Potentiation of Rifampicin as an Antifungal Agent against the Yeast Phase of Histoplasma capsulatum
Kobayashi, G. S., Medoff, G., Schlessinger, D., Kwan, C. N., & Musser, W. E. (1972) · Science · doi:10.1126/science.177.4050.709 · Cited by 75 · see citing works
Effectiveness of quinolone antibiotics in modulating the effects of antifungal drugs
Sugar, A. M., Liu, X. P., & Chen, R. J. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.11.2518 · Cited by 70 · see citing works
Demonstration of synergy with fluconazole and either ibuprofen, sodium salicylate, or propylparaben against Candida albicans in vitro
Scott, E. M., Tariq, V. N., & McCrory, R. M. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.12.2610 · Cited by 69 · see citing works
Exploring an antifungal target in the plasma membrane H+-ATPase of fungi
Seto‐Young, D., Monk, B. C., Mason, A. B., & Perlin, D. S. (1997) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(97)00028-x · Cited by 64 · see citing works
Myositis and Rhabdomyolysis Associated With Concurrent Use of Simvastatin and Nefazodone
Wang, P. (1997) · JAMA · doi:10.1001/jama.1997.03540280034021 · Cited by 63 · see citing works
In vitro activities of amphotericin B in combination with four antifungal agents and rifampin against Aspergillus spp
Hughes, C. E., Harris, C., Moody, J. A., Peterson, L. R., & Gerding, D. N. (1984) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.25.5.560 · Cited by 62 · see citing works
Pentamidine Inhibition of Group I Intron Splicing in Candida albicans Correlates with Growth Inhibition
Miletti, K. E., & Leibowitz, M. J. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.4.958-966.2000 · Cited by 61 · see citing works
Synergistic Action of Amphotericin Band Rifampin against Candida Species
Beggs, W. H., Sarosi, G. A., & Walker, M. I. (1976) · The Journal of Infectious Diseases · doi:10.1093/infdis/133.2.206 · Cited by 61 · see citing works
The Plasma Membrane H+‐ATPase of Fungi
Perlin, D. S., Seto‐Young, D., & Monk, B. C. (1997) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1997.tb52330.x · Cited by 60 · see citing works
In vitro and in vivo antifungal activities of DU-6859a, a fluoroquinolone, in combination with amphotericin B and fluconazole against pathogenic fungi
Nakajima, R., Kitamura, A., Someya, K., et al. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.7.1517 · Cited by 57 · see citing works
THE ANTIMICROBIAL ACTIVITIES OF CYCLOSPORINE, FK506, AND RAPAMYCIN
High, K. P. (1994) · Transplantation · doi:10.1097/00007890-199406270-00001 · Cited by 56 · see citing works
Effects of cyclosporine in experimental cryptococcal meningitis
Perfect, J. R., & Durack, D. T. (1985) · Infection and Immunity · doi:10.1128/iai.50.1.22-26.1985 · Cited by 54 · see citing works
Molecular Characterization of the Plasma Membrane H+-ATPase, an Antifungal Target inCryptococcus neoformans
Soteropoulos, P., Vaz, T., Santangelo, R., Paderu, P., Huang, D. Y., Tamás, M. J., & Perlin, D. S. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.9.2349-2355.2000 · Cited by 53 · see citing works
Activity of phenothiazines against medically important yeasts
Eilam, Y., Polacheck, I., Ben-Gigi, G., et al. (1987) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.31.5.834 · Cited by 52 · see citing works
Combination Antifungal Therapy in Treatment of Murine Pulmonary Mucormycosis: Roles of Quinolones and Azoles
Sugar, A. M., & Liu, X. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.7.2004-2006.2000 · Cited by 51 · see citing works
Invasive Aspergillosis in Mice Immunosuppressed with Cyclosporin A, Tacrolimus (FK506), or Sirolimus (Rapamycin)
High, K. P., & Washburn, R. G. (1997) · The Journal of Infectious Diseases · doi:10.1093/infdis/175.1.222 · Cited by 51 · see citing works
Conditional Lethality of the Diprotic Weak Bases Chloroquine and Quinacrine againstCryptococcus neoformans
Harrison, T. S., Griffin, G. E., & Levitz, S. M. (2000) · The Journal of Infectious Diseases · doi:10.1086/315649 · Cited by 49 · see citing works
Identification ofSaccharomyces cerevisiaeGenes Conferring Resistance to Quinoline Ring-Containing Antimalarial Drugs
Delling, U., Raymond, M., & Schurr, E. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.5.1034 · Cited by 45 · see citing works
Effect of fluvastatin and pravastatin, HMG-CoA reductase inhibitors, on fluconazole activity against Candida albicans
NASH, J. D., BURGESS, D. S., & TALBERT, R. L. (2002) · Journal of Medical Microbiology · doi:10.1099/0022-1317-51-2-105 · Cited by 44 · see citing works
Loss of function mutation in the yeast multiple drug resistance gene PDR5 causes a reduction in chloramphenicol efflux
Leonard, P., Rathod, P. K., & Golin, J. E. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.10.2492 · Cited by 44 · see citing works
Inhibitory effects of chlorpromazine on Candida species
Wood, N., & NUGENT, K. M. (1985) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.27.5.692 · Cited by 42 · see citing works
Combined effect of amphotericin B and rifampin on Candida species
Edwards, J. E., Morrison, J. O., Henderson, D. K., et al. (1980) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.17.3.484 · Cited by 41 · see citing works
Synergy of Nitric Oxide and Azoles against Candida Species In Vitro
McElhaney-Feser, G. E., Raulli, R. E., & Cihlar, R. L. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.9.2342 · Cited by 41 · see citing works
In Vitro Synergistic Interaction between Amphotericin B and Pentamidine against Scedosporium prolificans
Afeltra, J., Dannaoui, É., Meis, J. F. G. M., et al. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.10.3323-3326.2002 · Cited by 39 · see citing works
Self-citation
Synergistic action of amphotericin B and rifampin on Candida albicans.
Beggs, W. H., Sarosi, G. A., & Andrews, F. A. (1974) · PubMed · doi:10.1164/arrd.1974.110.5.671 · Cited by 39 · see citing works
Cyclosporin A inhibits Coccidioides immitis in vitro and in vivo
Kirkland, T. N., & Fierer, J. (1983) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.24.6.921 · Cited by 38 · see citing works
Antifungal Action of Rifampin
Medoff, G. (1983) · Clinical Infectious Diseases · doi:10.1093/clinids/5.supplement_3.s614 · Cited by 38 · see citing works
[Rhabdomyolysis in patients treated with simvastatin and cyclosporin: role of the hepatic cytochrome P450 enzyme system activity].
Meier, C. F., Stey, C., Brack, T., et al. (1995) · PubMed · Cited by 38 · see citing works
Proton-Pumping-ATPase-Targeted Antifungal Activity of a Novel Conjugated Styryl Ketone
Manavathu, E. K., Dimmock, J. R., Vashishtha, S. C., & Chandrasekar, P. H. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.12.2950 · Cited by 37 · see citing works
New systematically active antimycotics from the beta‐blocker category
Hänel, H., Kirsch, R., Schmidts, H. ‐., & Kottmann, H. E. (1995) · Mycoses · doi:10.1111/j.1439-0507.1995.tb00404.x · Cited by 37 · see citing works
The combination of amphotericin B and azithromycin as a potential new therapeutic approach to fusariosis
Clancy, C. J., & Nguyen, M. H. (1998) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/41.1.127 · Cited by 36 · see citing works
Use of decimal assay for additivity to demonstrate synergy in pair combinations of econazole, nikkomycin Z, and ibuprofen against Candida albicans in vitro
Tariq, V., Scott, E. M., & McCain, N. E. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.12.2615 · Cited by 35 · see citing works
Synergistic effect of ofloxacin and fluconazole against azole-resistant Candida albicans
Sasaki, E., Maesaki, S., Miyazaki, Y., Yanagihara, K., Tomono, K., Tashiro, T., & Kohno, S. (2000) · Journal of Infection and Chemotherapy · doi:10.1007/s101560070014 · Cited by 33 · see citing works
Chloroquine and the fungal phagosome
Weber, S. M., Levitz, S. M., & Harrison, T. S. (2000) · Current Opinion in Microbiology · doi:10.1016/s1369-5274(00)00102-8 · Cited by 31 · see citing works
Synergistic interaction of trimethoprim and sulfamethoxazole on Paracoccidioides brasiliensis
Stevens, D. A., & Vo, P. T. (1982) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.21.5.852 · Cited by 31 · see citing works
Inhibition of H+-ATPase-mediated proton pumping in Cryptococcus neoformans by a novel conjugated styryl ketone
Manavathu, E. K. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/47.4.491 · Cited by 31 · see citing works
Combined in vitro effect of amphotericin B and rifampin on Cryptococcus neoformans
Fujita, N. K., & Edwards, J. E. (1981) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.19.1.196 · Cited by 30 · see citing works
Inhibition of Germ Tube Formation by Candida albicans by Local Anesthetics: An Effect Related to Ionic Channel Blockade
Rodrigues, A. G., Pina‐Vaz, C., Mårdh, P., Martinez‐de‐Oliveira, J., & Fonseca, A. F. D. (2000) · Current Microbiology · doi:10.1007/s002849910030 · Cited by 30 · see citing works
Proton translocating ATPase mediated fungicidal activity of a novel complex carbohydrate: CAN-296
Ben-Josef, A. M., Manavathu, E. K., Platt, D. M., et al. (2000) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(99)00140-5 · Cited by 30 · see citing works
In vitro susceptibility studies of Cryptococcus neoformans isolated from patients with no clinical response to amphotericin B therapy
Rodero, L., Córdoba, S. B., Cahn, P. E., Hochenfellner, F., Davel, G., Canteros, C. E., Kaufman, S. C., & Guelfand, L. I. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/45.2.239 · Cited by 30 · see citing works
Combined Amphotericin B-Tetracycline Therapy for Experimental Coccidioidomycosis
Huppert, M., Sun, S. H., & Vukovich, K. R. (1974) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.5.5.473 · Cited by 29 · see citing works
Effects of pentamidine isethionate on Saccharomyces cerevisiae
Ludewig, G., Williams, J. M., Li, Y., & Stäben, C. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.5.1123 · Cited by 29 · see citing works
In Vitro Activities of Pentamidine, Pyrimethamine, Trimethoprim, and Sulfonamides against Aspergillus Species
Afeltra, J., Meis, J. F. G. M., Vitale, R. G., et al. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.6.2029-2031.2002 · Cited by 24 · see citing works
Self-citation
The spectrum of aspergillosis in liver transplant patients: comparison of FK 506 and cyclosporine immunosuppression.
Torre‐Cisneros, J., Máñez, R., Kusne, S., ALESSIANI, M., Martin, M., & Starzl, T. E. (1991) · PubMed · Cited by 23 · see citing works
N-acetylcysteine inhibits germination of conidia and growth of Aspergillus spp. and Fusarium spp
Lucca, A. J. D., Walsh, T. J., & Daigle, D. J. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.5.1274 · Cited by 23 · see citing works
Inhibition of hyphal growth ofCandida albicansby activated lansoprazole, a novel benzimidazole proton pump inhibitor
Biswas, S. K., Yokoyama, K., Kamei, K., et al. (2001) · Medical Mycology · doi:10.1080/mmy.39.3.283.285 · Cited by 21 · see citing works
In Vitro Inhibition of Coccidioides Immitis Strains with Amphotericin B Plus Rifampin
Rifkind, D., Crowder, E. D., & Hyland, R. N. (1974) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.6.6.783 · Cited by 20 · see citing works
Effects of pentamidine alone and in combination with ketoconazole or itraconazole on the growth of Candida albicans
St‐Germain, G. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.12.2304 · Cited by 20 · see citing works
Bleomycin therapy of experimental disseminated candidiasis in mice
Graybill, J. R., Bocanegra, R. A., Fothergill, A. W., & Rinaldi, M. G. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.3.816 · Cited by 16 · see citing works
Detection, with a pH indicator, of bacterial mutants unable to denitrify
Mazoch, J., & Kučera, I. (2002) · Journal of Microbiological Methods · doi:10.1016/s0167-7012(02)00059-3 · Cited by 15 · see citing works
Effect of pentamidine on the growth of Cryptococcus neoformans
Barchiesi, F., Poeta, M. D., Morbiducci, V., et al. (1994) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/33.6.1229 · Cited by 14 · see citing works
Combinations of Antifungal and Antineoplastic Drugs with Interactive Effects on Inhibition of Yeast Growth
Ghannoum, M. A., Abu‐Elteen, K. H., Motawy, M. S., et al. (2009) · Chemotherapy · doi:10.1159/000238782 · Cited by 14 · see citing works
Effects of the combination of ketoconazole and calcium channel antagonists against Candida albicans in vitro.
Krajewska-Kułak, E., & Niczyporuk, W. (1993) · PubMed · Cited by 13 · see citing works
Influence of calcium channel blockers on polymorphonuclear and monocyte bactericidal and fungicidal activity.
Lévy, R., Dana, R., Gold, B., et al. (1991) · PubMed · Cited by 12 · see citing works
Discrepancy betweenin vitroandin vivoantifungal activity of albendazole
Hardin, T. C., Najvar, L. K., Rizzo, J., et al. (1997) · Medical Mycology · doi:10.1080/02681219780001081 · Cited by 12 · see citing works
The effect of nebulised pentamidine on the concentration of intra-oral Candida albicans in HIV-infected patients
Nolan, A., Lamey, P. J., MacFarlane, T. W., et al. (1994) · Journal of Medical Microbiology · doi:10.1099/00222615-41-2-95 · Cited by 11 · see citing works
In-vitro and in-vivo susceptibility of Aspergillus fumigatus to a novel conjugated styryl ketone
Manavathu, E. K. (1998) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/42.5.585 · Cited by 11 · see citing works
Combined activity of ketoconazole and sulphamethoxazole against Candida albicans
Beggs, W. H. (1982) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/10.6.539 · Cited by 10 · see citing works
Prevention of invasive aspergillosis in AIDS by sulfamethoxazole
Afeltra, J., Meis, J. F. G. M., Mouton, J. W., et al. (2001) · AIDS · doi:10.1097/00002030-200105250-00020 · Cited by 9 · see citing works
Self-citation
Anti- Candida Activity of a New Platinum Derivative
Watanabe, T., Takano, M., Ogasawara, A., et al. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.10.2853-2854.2000 · Cited by 8 · see citing works
Modification of responses of Candida albicans to cisplatin by membrane damaging antimycotic agents
Sarachek, A., & Henderson, L. A. (1991) · Mycoses · doi:10.1111/j.1439-0507.1991.tb00640.x · Cited by 7 · see citing works
Can Antitumor Platinum Compounds Be Effective against Candida albicans ?— A Screening Assay Using Disk Diffusion Method
Chandrasekar, K., Shyla, J. H., & Malathi, R. (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.10.3905-3905.2000 · Cited by 6 · see citing works
Evaluation of the genotoxic spectrum of cisplatin for Candida albicans.
Sarachek, A., Henderson, L. A., & We, W. (1992) · PubMed · Cited by 6 · see citing works
Anticandidal activity of flunarizine.
Krajewska-Kułak, E., & Niczyporuk, W. (1994) · PubMed · Cited by 5 · see citing works
[Diminution of antifungal activity of fluconazole associated with ibuprofen and piroxicam in experimental histoplasmosis of hamsters (Mesocricetus auratus)]
Finquelievich, J. L., Iovannitti, C., Landaburu, F., et al. (2002) · PubMed · Cited by 5 · see citing works

Flagged first, then by citations

Sorted by citations

High-throughput synergy screening identifies microbial metabolites as combination agents for the treatment of fungal infections
Zhang, L., Yan, K., Zhang, Y., Huang, R., Bian, J., Zheng, C., Sun, H., Chen, Z., Sun, N., An, R., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0609370104 · Cited by 248 · see citing works
Antifungal Activity of Tamoxifen: In Vitro and In Vivo Activities and Mechanistic Characterization
Dolan, K., Montgomery, S., Buchheit, B., DiDone, L., Wellington, M., & Krysan, D. J. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01564-08 · Cited by 112 · see citing works
In vitro synergistic interactions of the effects of various statins and azoles against some clinically important fungi: Synergistic interactions between statins and azoles
Nyilasi, I., Kocsubé, S., Krizsán, K., Galgóczy, L., Pesti, M., Papp, T., & Vágvölgyi, C. (2010) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2010.01972.x · Cited by 83 · see citing works
Repurposing antipsychotic drugs into antifungal agents: Synergistic combinations of azoles and bromperidol derivatives in the treatment of various fungal infections
Holbrook, S. Y. L., Garzan, A., Dennis, E. K., Shrestha, S. K., & Garneau-Tsodikova, S. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.07.030 · Cited by 51 · see citing works
Direct effects of non-antifungal agents used in cancer chemotherapy and organ transplantation on the development and virulence ofCandidaandAspergillusspecies
Chen, S. C.-A., Lewis, R. E., & Kontoyiannis, D. P. (2011) · Virulence · doi:10.4161/viru.2.4.16764 · Cited by 41 · see citing works
In vitro interactions between primycin and different statins in their effects against some clinically important fungi
Nyilasi, I., Kocsubé, S., Pesti, M., Lukács, G., Papp, T., & Vágvölgyi, C. (2010) · Journal of Medical Microbiology · doi:10.1099/jmm.0.013946-0 · Cited by 35 · see citing works
Statins as antifungal agents
Galgóczy, L. (2011) · World Journal of Clinical Infectious Diseases · doi:10.5495/wjcid.v1.i1.4 · Cited by 21 · see citing works
In vitro interaction between suramin and fluvastatin against clinically important Zygomycetes
Galgóczy, L., Papp, T., & Vágvölgyi, C. (2009) · Mycoses · doi:10.1111/j.1439-0507.2008.01634.x · Cited by 14 · see citing works

The Effect of Ketoconazole on Amphotericin B in a Model of Disseminated Aspergillosis
Schaffner, A., & Frick, P. G. (1985) · The Journal of Infectious Diseases · doi:10.1093/infdis/151.5.902 · Cited by 176 · see citing works
Treatment of canine blastomycosis with amphotericin B and ketoconazole
Legendre, A. Μ., Selcer, B. A., Edwards, D. F., et al. (1984) · Journal of the American Veterinary Medical Association · doi:10.2460/javma.1984.184.10.1249 · Cited by 38 · see citing works
Combination Therapy of Experimental Histoplasmosis and Cryptococcosis with Amphotericin Band Ketoconazole
Graybill, J. R., Williams, D. M., Cutsem, E. V., et al. (1980) · Clinical Infectious Diseases · doi:10.1093/clinids/2.4.551 · Cited by 67 · see citing works
Interaction of Rifampin with Other Antifungal Agents in Experimental
Candidiasis, M., Graybill, J. R., Ahrens, J., et al. (2016)
Interactions among amphotericin B, 5-fluorocytosine, ketoconazole, and miconazole against pathogenic fungi in vitro
Odds, F. C. (1982) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.22.5.763 · Cited by 110 · see citing works

Authors: Afeltra, J., & Verweij, P. E.
Affiliations: Radboud University Nijmegen (NL)
Corresponding author: Verweij, P. E.
ORCID: Verweij, P. E.
Venue: European Journal of Clinical Microbiology & Infectious Diseases
Publisher: Springer Science and Business Media LLC
Published: 2003-07-01
Volume: 22
Issue: 7
Pages: 397-407
ISSN: 0934-9723 (ISSN-L)
1435-4373
DOI: 10.1007/s10096-003-0947-x
OpenAlex: W2089867899
Cited by: 63
References: 102
Citations by year: 2026: 1 · 2025: 3 · 2024: 5 · 2023: 2 · 2022: 1 · 2021: 5 · 2020: 5 · 2019: 1 · 2018: 1 · 2017: 6 · 2016: 2 · 2015: 3 · 2014: 3 · 2013: 3 · 2012: 4
FWCI: 0.19
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: European Journal of Clinical Microbiology & Infectious Diseases (publishedVersion)
PubMed (publishedVersion)
Radboud Repository (Radboud University) (submittedVersion)
Topics: Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
Health Sciences › Medicine › Epidemiology › Fungal Infections and Studies
Life Sciences › Agricultural and Biological Sciences › Ecology, Evolution, Behavior and Systematics › Fungal Plant Pathogen Control
Keywords: antifungal activity, drug repurposing, chlorpromazine, proton pump inhibitors, antiarrhythmic drugs, cholesterol-lowering drugs, anticancer agents, immunosuppressants, antiparasitic drugs, antibiotics, antifungal resistance, combination antifungal therapy, invasive fungal infections, fungal infection
MeSH terms: Adrenergic beta-Antagonists, Anti-Arrhythmia Agents, Anti-Infective Agents, Antifungal Agents, Antineoplastic Agents, Fungi, Immunosuppressive Agents, Models, Biological, Antipsychotic Agents

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Antifungal Activity of Nonantifungal Drugs

Abstract

Integrity signals

Claims the paper makes

Claims other papers make about this one

Cites

Cited by

Related

Record

About these checks